These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 2170822

  • 1. Pharmacokinetics of oestrogens and progestogens.
    Kuhl H.
    Maturitas; 1990 Sep; 12(3):171-97. PubMed ID: 2170822
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical use of oestrogens and progestogens.
    Lauritzen C.
    Maturitas; 1990 Sep; 12(3):199-214. PubMed ID: 2215269
    [Abstract] [Full Text] [Related]

  • 4. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
    Said S, Sadek W, Rocca M, Koetsawang S, Kirwat O, Piya-Anant M, Dusitsin N, Sethavanich S, Affandi B, Hadisaputra W, Kazi A, Ramos RM, d'Arcangues C, Belsey EM, Noonan E, Olayinka I, Pinol A.
    Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
    [Abstract] [Full Text] [Related]

  • 6. Risks of estrogens and progestogens.
    L'Hermite M.
    Maturitas; 1990 Sep; 12(3):215-46. PubMed ID: 2170823
    [Abstract] [Full Text] [Related]

  • 7. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE, Bolt HM, Zwirner M, Hochlehnert G, Göser R.
    Arzneimittelforschung; 1982 Sep; 32(7):787-91. PubMed ID: 6289846
    [Abstract] [Full Text] [Related]

  • 8. The influence of pharmaceutical compounds on male fertility.
    Neumann F, Diallo FA, Hasan SH, Schenck B, Traore I.
    Andrologia; 1976 Sep; 8(3):203-35. PubMed ID: 793446
    [Abstract] [Full Text] [Related]

  • 9. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K, Sami GE, Wassef SA, Nour H, Hassan AA.
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [Abstract] [Full Text] [Related]

  • 10. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
    Eldon MA, Underwood BA, Randinitis EJ, Sedman AJ.
    Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
    [Abstract] [Full Text] [Related]

  • 11. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy.
    Fotherby K.
    Contraception; 1996 Aug; 54(2):59-69. PubMed ID: 8842581
    [Abstract] [Full Text] [Related]

  • 13. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women.
    Baumann A, Fuhrmeister A, Brudny-Klöppel M, Draeger C, Bunte T, Kuhnz W.
    Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Baumann A, Staks T, Dibbelt L, Knuppen R, Jütting G.
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [Abstract] [Full Text] [Related]

  • 15. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
    Kharma K, Stone S, Thorneycroft IH, Nakamura RM, Mishell DR.
    Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES, Cruickshank J, McMaster M, Weir RJ.
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [Abstract] [Full Text] [Related]

  • 18. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J.
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [Abstract] [Full Text] [Related]

  • 19. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW, Martin J, Lynch M.
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.